Try our Advanced Search for more refined results
February 07, 2013
GLAXOSMITHKLINE LLC v. TEVA PHARMACEUTICALS USA, INC.
Case Number:
2:13-cv-00726
Court:
Nature of Suit:
Other Statutes: Other Statutory Actions
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 24, 2014
GSK Blasts Teva's Use Of Pom Ruling To Nix False-Ad Suit
GlaxoSmithKline LLC criticized Teva Pharmaceuticals USA Inc.'s request for reconsideration of a Pennsylvania federal judge's refusal to dismiss GSK's suit, which accuses Teva of falsely advertising a generic antidepressant as equivalent to Wellbutrin, arguing Tuesday that Teva misinterpreted Pom Wonderful.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login